WCN25-888 DESIGN OF THE ZEUS TRIAL: INTERLEUKIN 6 INHIBITION WITH ZILTIVEKIMAB FOR CARDIOVASCULAR PROTECTION IN CHRONIC KIDNEY DISEASE
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S246802492403376X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849330183019954176 |
|---|---|
| author | Vlado Perkovic Katherine Tuttle Naveed Sattar A. Michael Lincoff Ann M. Navar Nikolaus Marx Anders Hvelplund Florian M.M. Baeres Mads D. Engelmann G. Kees Hovingh Paul M. Ridker |
| author_facet | Vlado Perkovic Katherine Tuttle Naveed Sattar A. Michael Lincoff Ann M. Navar Nikolaus Marx Anders Hvelplund Florian M.M. Baeres Mads D. Engelmann G. Kees Hovingh Paul M. Ridker |
| author_sort | Vlado Perkovic |
| collection | DOAJ |
| format | Article |
| id | doaj-art-69191d769cde4e58be52c194904b1203 |
| institution | Kabale University |
| issn | 2468-0249 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-69191d769cde4e58be52c194904b12032025-08-20T03:47:02ZengElsevierKidney International Reports2468-02492025-02-01102S767S76810.1016/j.ekir.2024.11.1354WCN25-888 DESIGN OF THE ZEUS TRIAL: INTERLEUKIN 6 INHIBITION WITH ZILTIVEKIMAB FOR CARDIOVASCULAR PROTECTION IN CHRONIC KIDNEY DISEASEVlado Perkovic0Katherine Tuttle1Naveed Sattar2A. Michael Lincoff3Ann M. Navar4Nikolaus Marx5Anders Hvelplund6Florian M.M. Baeres7Mads D. Engelmann8G. Kees Hovingh9Paul M. Ridker10The George Institute for Global Health, The University of New South Wales, Sydney, AustraliaSchool of Medicine, University of Washington and Providence Inland Northwest Health, Spokane, United StatesSchool of Cardiovascular & Metabolic Health, University of Glasgow, Glasgow, United KingdomDepartment of Cardiovascular Medicine, Cleveland Clinic, Cleveland, United StatesDepartment of Internal Medicine, University of Texas Southwestern Medical Centre, Dallas, United StatesDepartment of Internal Medicine I, University Hospital Aachen, Aachen, GermanyGlobal Development Projects, Novo Nordisk A/S, Søborg, DenmarkGlobal Medical Affairs, Novo Nordisk A/S, Søborg, DenmarkClinical Drug Development, Novo Nordisk A/S, Søborg, DenmarkGlobal Chief Medical Office, Novo Nordisk A/S, Søborg, DenmarkCenter for Cardiovascular Disease Prevention and the Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, United Stateshttp://www.sciencedirect.com/science/article/pii/S246802492403376X |
| spellingShingle | Vlado Perkovic Katherine Tuttle Naveed Sattar A. Michael Lincoff Ann M. Navar Nikolaus Marx Anders Hvelplund Florian M.M. Baeres Mads D. Engelmann G. Kees Hovingh Paul M. Ridker WCN25-888 DESIGN OF THE ZEUS TRIAL: INTERLEUKIN 6 INHIBITION WITH ZILTIVEKIMAB FOR CARDIOVASCULAR PROTECTION IN CHRONIC KIDNEY DISEASE Kidney International Reports |
| title | WCN25-888 DESIGN OF THE ZEUS TRIAL: INTERLEUKIN 6 INHIBITION WITH ZILTIVEKIMAB FOR CARDIOVASCULAR PROTECTION IN CHRONIC KIDNEY DISEASE |
| title_full | WCN25-888 DESIGN OF THE ZEUS TRIAL: INTERLEUKIN 6 INHIBITION WITH ZILTIVEKIMAB FOR CARDIOVASCULAR PROTECTION IN CHRONIC KIDNEY DISEASE |
| title_fullStr | WCN25-888 DESIGN OF THE ZEUS TRIAL: INTERLEUKIN 6 INHIBITION WITH ZILTIVEKIMAB FOR CARDIOVASCULAR PROTECTION IN CHRONIC KIDNEY DISEASE |
| title_full_unstemmed | WCN25-888 DESIGN OF THE ZEUS TRIAL: INTERLEUKIN 6 INHIBITION WITH ZILTIVEKIMAB FOR CARDIOVASCULAR PROTECTION IN CHRONIC KIDNEY DISEASE |
| title_short | WCN25-888 DESIGN OF THE ZEUS TRIAL: INTERLEUKIN 6 INHIBITION WITH ZILTIVEKIMAB FOR CARDIOVASCULAR PROTECTION IN CHRONIC KIDNEY DISEASE |
| title_sort | wcn25 888 design of the zeus trial interleukin 6 inhibition with ziltivekimab for cardiovascular protection in chronic kidney disease |
| url | http://www.sciencedirect.com/science/article/pii/S246802492403376X |
| work_keys_str_mv | AT vladoperkovic wcn25888designofthezeustrialinterleukin6inhibitionwithziltivekimabforcardiovascularprotectioninchronickidneydisease AT katherinetuttle wcn25888designofthezeustrialinterleukin6inhibitionwithziltivekimabforcardiovascularprotectioninchronickidneydisease AT naveedsattar wcn25888designofthezeustrialinterleukin6inhibitionwithziltivekimabforcardiovascularprotectioninchronickidneydisease AT amichaellincoff wcn25888designofthezeustrialinterleukin6inhibitionwithziltivekimabforcardiovascularprotectioninchronickidneydisease AT annmnavar wcn25888designofthezeustrialinterleukin6inhibitionwithziltivekimabforcardiovascularprotectioninchronickidneydisease AT nikolausmarx wcn25888designofthezeustrialinterleukin6inhibitionwithziltivekimabforcardiovascularprotectioninchronickidneydisease AT andershvelplund wcn25888designofthezeustrialinterleukin6inhibitionwithziltivekimabforcardiovascularprotectioninchronickidneydisease AT florianmmbaeres wcn25888designofthezeustrialinterleukin6inhibitionwithziltivekimabforcardiovascularprotectioninchronickidneydisease AT madsdengelmann wcn25888designofthezeustrialinterleukin6inhibitionwithziltivekimabforcardiovascularprotectioninchronickidneydisease AT gkeeshovingh wcn25888designofthezeustrialinterleukin6inhibitionwithziltivekimabforcardiovascularprotectioninchronickidneydisease AT paulmridker wcn25888designofthezeustrialinterleukin6inhibitionwithziltivekimabforcardiovascularprotectioninchronickidneydisease |